Verrica Pharmaceuticals Inc. financial data

Symbol
VRCA on Nasdaq
Location
West Chester, PA
Fiscal year end
31 December
Latest financial report
11 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 149% % -29%
Quick Ratio 9.2% % -20%
Debt-to-equity -697% % -49%
Return On Equity 252% % -54%
Return On Assets -42% % 72%
Operating Margin -263% % 55%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17,178,786 shares -81%
Common Stock, Shares, Outstanding 17,178,786 shares 87%
Entity Public Float $27,300,000 USD -86%
Common Stock, Value, Issued $2,000 USD 100%
Weighted Average Number of Shares Outstanding, Basic 10,652,367 shares 106%
Weighted Average Number of Shares Outstanding, Diluted 10,652,367 shares 106%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $14,344,000 USD
Revenue from Contract with Customer, Excluding Assessed Tax $14,704,000 USD 5.7%
Cost of Revenue $2,600,000 USD 0%
Research and Development Expense $8,855,000 USD -25%
Operating Income (Loss) $12,185,000 USD 82%
Nonoperating Income (Expense) $5,701,000 USD 47%
Net Income (Loss) Attributable to Parent $17,886,000 USD 77%
Earnings Per Share, Basic -1.68 USD/shares 89%
Earnings Per Share, Diluted -1.68 USD/shares 89%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $30,147,000 USD -35%
Cash, Cash Equivalents, and Short-term Investments $10,000,000 USD
Accounts Receivable, after Allowance for Credit Loss, Current $5,260,000 USD 10858%
Inventory, Net $2,236,000 USD -9.2%
Assets, Current $42,539,000 USD -17%
Property, Plant and Equipment, Net $209,000 USD -65%
Operating Lease, Right-of-Use Asset $540,000 USD -35%
Other Assets, Noncurrent $376,000 USD 0%
Assets $47,131,000 USD -13%
Accounts Payable, Current $2,072,000 USD 9.3%
Employee-related Liabilities, Current $1,763,000 USD 50%
Contract with Customer, Liability, Current $782,000 USD
Liabilities, Current $16,437,000 USD -43%
Operating Lease, Liability, Noncurrent $242,000 USD -58%
Liabilities $22,388,000 USD -65%
Retained Earnings (Accumulated Deficit) $324,913,000 USD -5.8%
Stockholders' Equity Attributable to Parent $24,743,000 USD
Liabilities and Equity $47,131,000 USD -13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,677,000 USD 36%
Net Cash Provided by (Used in) Financing Activities $4,057,000 USD -514%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 17,189,300 shares 87%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $16,734,000 USD 19%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30,147,000 USD -35%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,535,000 USD -16%
Deferred Tax Assets, Valuation Allowance $73,738,000 USD 4%
Deferred Tax Assets, Gross $74,127,000 USD 3.9%
Operating Lease, Liability $583,000 USD -35%
Depreciation $133,000 USD -61%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid $612,000 USD -37%
Property, Plant and Equipment, Gross $1,259,000 USD -32%
Operating Lease, Liability, Current $341,000 USD 8.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $246,000 USD -33%
Lessee, Operating Lease, Liability, to be Paid, Year One $366,000 USD 1.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.0625 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $29,000 USD -61%
Lessee, Operating Lease, Liability, to be Paid, Year Three $0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards $58,664,000 USD 8.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $0 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $389,000 USD -19%
Share-based Payment Arrangement, Expense $3,318,000 USD -54%
Interest Expense $8,649,000 USD 35938%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%